Interest in psychedelic therapy is growing across Canada, but marketing claims often move faster than clinical evidence. Here is how to assess promises, legal boundaries, provider quality, and personal risk.
Tag Archives: psychedelic research
News about psychedelic companies, research programs, and criminal cases is changing how Canadians think about psilocybin access. This guide explains the difference between regulated research, unauthorized sales, and responsible consumer education.
Canada’s psychedelic research landscape is shifting fast in 2026, with new clinical trial milestones, policy signals, and commercial production news. Here’s what that means for everyday magic mushroom users, microdosers, and buyers of psilocybin products.
A 2026 fish study on psilocybin and aggression has reignited interest in how magic mushrooms affect emotional regulation. Here’s what the science actually shows, what Canadian clinical signals mean, and how users can apply it responsibly.
Psilocybin and LSD are edging closer to FDA approval in the United States — a milestone that could reshape how Canada treats psychedelics. We break down what the news actually says, what it doesn’t, and how it affects Canadian magic mushroom buyers, dispensaries, and delivery services.